Cancer News and Research

Latest Cancer News and Research

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.

21 Jun 2023

Gestational diabetes influences diabetes risk and blood sugar control

People who develop diabetes following pregnancy were significantly less likely to be able to bring it under control if they had experienced gestational diabetes during their pregnancy, especially if they were Black or Hispanic, according to a Mount Sinai study published on June 21 in the journal Diabetes Care.

21 Jun 2023

Study finds stark racial and ethnic disparities in alcohol-induced mortality among US adults during the pandemic

Alcohol-related deaths rose disproportionately quickly in the US among Black, Hispanic, Asian and American-Indian/Alaska Native populations at the start of the COVID-19 pandemic, new research shows.

21 Jun 2023

Novel approach to multimodal aging clock for interpretable age prediction and target discovery

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 11, entitled, "Precious1GPT: multimodal transformer-based transfer learning for aging clock development and feature importance analysis for aging and age-related disease target discovery."

21 Jun 2023

New insights into lymphatic cell migration and lymphatic vessel remodeling

Lymphangiogenesis refers to the formation and remodeling of lymphatic vessels (a network of thin tubes that carry lymph in the lymphatic system), and it supports the transport of molecules and immune cells around the body.

21 Jun 2023

Study investigates whether metformin mitigates androgen deprivation therapy-related metabolic syndrome

A new research paper was published in Oncotarget's Volume 14 on June 19, 2023, entitled, "Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer."

21 Jun 2023

Building resilient brains: strategies for promoting brain health in older adults

Researchers reviewed the overarching theme of brain health from the perspective of aging and preventive care.

21 Jun 2023

The Fight Against Antimicrobial Resistance: A Promising Broad Host-Range CRISPR-Cas9 Delivery Tool for AMR Plasmid Removal

Study removes AMR plasmids using a mobile, broad-host-range CRISPR-Cas9 delivery tool.

21 Jun 2023

Newborn screening facilitates early identification of infants with severe combined immunodeficiency

Introducing widespread screening of newborns for a deadly disease called severe combined immunodeficiency, or SCID, followed by early treatment boosted the five-year survival rate of children with the disorder from 73% before the advent of screening to 87% since, researchers report.

20 Jun 2023

Rensselaer investigator awarded $1.6 million grant to study the mechanics of mitosis to fight cancer

It is a scary fact that one in two women and one in three men in the United States will develop some form of cancer in their lifetime.

20 Jun 2023

$3.3M HHS grant supports UTHealth Houston study on combination treatment strategy for pancreatic cancer

A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.

20 Jun 2023

UTHSC researchers receive major national award to find new treatments for breast cancer metastasis

UTHSC researchers working to find new treatments to combat breast cancer metastasis recently pulled in a major national award.

20 Jun 2023

Targeting Phage Therapy 2023 showcased the progress and possibilities of phage therapy in future

The 6th World Congress on Targeting Phage Therapy 2023 that was held on June 1-2 in Paris, and gathered more than 150 attendees from 30+ different countries. Targeting Phage Therapy 2023 included more than 71 presentations between major talks, short orals, and posters.

20 Jun 2023

New study reveals the hidden mechanism between cancer and diabetes

Back in the 1920s, researchers discovered that cancer patients had sweet-smelling urine. First, the doctors were puzzled, but they soon realised that it was a result of elevated blood sugar levels.

20 Jun 2023

New measurement tool helps analyze quality of life after childhood cancer

A new measurement tool helps analyze the survival rate of children with cancer, but also the quality of survival.

20 Jun 2023

Radiation combined with cancer-targeting virus therapy more effective in fighting brain tumors

Combining a cancer-targeting virus with radiation to treat brain cancer in mice was more effective than either therapy on its own according to University of Alberta research, providing hope for new treatments that combine immunotherapy with traditional surgery, chemotherapy or radiation.

20 Jun 2023

New treatment could be instrumental in restoring the blood-brain barrier's normal function

There's a bouncer in everyone: The blood-brain barrier, a layer of cells between blood vessels and the rest of the brain, kicks out toxins, pathogens and other undesirables that can sabotage the brain's precious gray matter.

20 Jun 2023

INTEGRA Biosciences’ pipettes help to advance cancer drug discovery

The Institute for Cancer Research (ICR), part of the University of London, is using VIAFLO electronic pipettes from INTEGRA Biosciences to streamline its preclinical drug screening and translational medicine workflows.

From INTEGRA Biosciences 20 Jun 2023

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, an engineered T cell receptor natural killer (TCR NK) cell therapy for advanced synovial sarcoma and myxoid/round cell liposarcoma.

20 Jun 2023

Pioneering methodology reveals novel biomarkers for non-small cell lung cancer

Researchers of the University of Barcelona and the Institute of Bioengineering of Catalonia have identified new biomarkers for non-small cell lung cancer, the most common lung cancer.

20 Jun 2023

Cancer News and Research

Latest Cancer News and Research

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

Gestational diabetes influences diabetes risk and blood sugar control

Study finds stark racial and ethnic disparities in alcohol-induced mortality among US adults during the pandemic

Novel approach to multimodal aging clock for interpretable age prediction and target discovery

New insights into lymphatic cell migration and lymphatic vessel remodeling

Study investigates whether metformin mitigates androgen deprivation therapy-related metabolic syndrome

Building resilient brains: strategies for promoting brain health in older adults

The Fight Against Antimicrobial Resistance: A Promising Broad Host-Range CRISPR-Cas9 Delivery Tool for AMR Plasmid Removal

Newborn screening facilitates early identification of infants with severe combined immunodeficiency

Rensselaer investigator awarded $1.6 million grant to study the mechanics of mitosis to fight cancer

$3.3M HHS grant supports UTHealth Houston study on combination treatment strategy for pancreatic cancer

UTHSC researchers receive major national award to find new treatments for breast cancer metastasis

Targeting Phage Therapy 2023 showcased the progress and possibilities of phage therapy in future

New study reveals the hidden mechanism between cancer and diabetes

New measurement tool helps analyze quality of life after childhood cancer

Radiation combined with cancer-targeting virus therapy more effective in fighting brain tumors

New treatment could be instrumental in restoring the blood-brain barrier's normal function

INTEGRA Biosciences’ pipettes help to advance cancer drug discovery

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Pioneering methodology reveals novel biomarkers for non-small cell lung cancer

Industry Focus: Cell & Gene Therapy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in